Recently, the Energy Bureau of the Inner Mongolia Autonomous Region released the first batch list of independent new-type energy storage construction projects for 2026.
Recently, Valiant Pharmaceutical’s first active pharmaceutical ingredient (API), olmesartan medoxomil, successfully passed the rigorous review of the European Directorate for the Quality of Medicines and HealthCare (EDQM) and obtained the Certificate of Suitability to the European Pharmacopoeia (CEP), supported by its advanced and independently developed research and production process.
On March 12, Liao Jiasheng, Chairman of CECEP, met with Zeng Yuqun, Chairman and CEO of CATL, and his delegation at CECEP headquarters.
From December 8 to 12, the Seventh United Nations Environment Assembly was held in Nairobi, Kenya.
Recently, at the 2025 Golden Bull Corporate Sustainable Development Forum themed “Good Governance for Long-Term Progress, Green Momentum for the Future”, Valiant, a subsidiary of CECEP, was awarded the third CRHC Cup · ESG Golden Bull Award.
From December 4 to 5, Cao Huabin, Deputy General Manager of CECEP, attended the Fourth Session of the Eighth Council of the China International Contractors Association (CHINCA) and the Association’s 2025 Annual Industry Conference in Zhengzhou, Henan Province. 
Recently, CECEPEC, a subsidiary of CECEPHK, was certified for the fifth consecutive year by the Hong Kong Monetary Authority (HKMA) as an approved external reviewer under the Green and Sustainable Finance Grant Scheme.
Recently, CGM, a subsidiary of CGC, successfully won the bid for the Mechanical Core Drilling Project for Three 1:50,000 Regional Mineral Geological Survey Sheets in Northern Laos. This marks a major breakthrough in CGM’s market development and reflects CGC’s active efforts to support the Belt and Road Initiative and advance practical cooperation based on its core business.
第  20  /  44  页  总条数: 217
Produced By CMS 网站群内容管理系统 publishdate:2026-07-07 16:19:35